Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179306 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211982 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 211988 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211992 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-12-14 | 2024-02-01 | 213371 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-06-07 | 2024-07-26 | 229954 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-07-04 | 2024-09-05 | 232226 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-07-18 | 2024-11-14 | 233267 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-09-05 | 2024-09-19 | 236813 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-09 | 92140 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133448 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-04-15 | 2021-05-20 | 137541 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141110 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-09-02 | 2021-12-01 | 145115 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146112 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146456 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-10-07 | 2021-11-11 | 146847 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |